16 San Francisco biopharma companies could be negatively impacted by Inflation Reduction Act drug provision

16 San Francisco biopharma companies could be negatively impacted by Inflation Reduction Act drug provision
Sally Pipes, president, Pacific Research Institute, left, and President Joe Biden (D) delivering his 2024 State of the Union address — Pacific Research Institute / WhiteHouse.gov
0Comments

A provision of the “Inflation Reduction Act” (IRA) could threaten investments in “small molecule” drug development, said the head of the Pasadena-based Pacific Research Institute (PRI).

There are currently up to 16 San Francisco biopharma companies involved in that type of drug development, according to Biopharmguy.com

PRI President Sally Pipes told South SFV Today on Feb 26 that a so-called “small molecule penalty” in the Inflation IRA will “have an outsized impact on our efforts to development treatments for cancer.”

Pipes said that the announcement by Stanford Researchers in December that they had discovered an “on/off switch” for breast cancer is but one example of a “small molecule” drug innovation.

The IRA, signed into law by President Joe Biden (D) in 2022, contains a drug provision in which the brand-name drugs for which Medicare “negotiates” prices are split into two categories: small-molecule drugs and biologics. 

The IRA makes small-molecule drugs eligible for “negotiation” nine years after their approval, compared to a 13-year exemption period for biologics.

“While both small-molecule drugs and biologics are essential for cancer treatment, small-molecule drugs are the only way to target some forms of breast, lung, colon, and other cancers,” she said. 

An October 2023 paper, authored by University of Chicago economists, said that the IRA small molecule provision will result in “188 fewer small molecule treatments, including 79 fewer new small molecule drugs and 109 fewer post-approval indications for these drugs.”


How many California biopharma companies are involved in “small molecule” drug development? 

Source: Biopharmguy.com 

Company City/Town Type of Drug Development
Hinge Therapeutics CA – Sunnyvale AI Small Molecule Drug Discovery
Peak Bio CA – Palo Alto Antibody-Drug Conjugates, Small Molecules
Tracon Pharmaceuticals CA – San Diego Biologics, Small Molecules
FibroGen CA – San Francisco Biologics, Small Molecules
Healis Therapeutics CA – Newport Beach Botox Neuro Treatment
Kairos Pharma CA – Los Angeles Cell Therapy, Antibodies, Small Molecules
Alion Pharmaceuticals CA – Menlo Park Chemistry services, small molecules
Totus Medicines CA – Emeryville Covalent Small Molecules
Terremoto Biosciences CA – San Francisco Covalent Small Molecules
Anagenex CA – San Francisco Directed Evolution Platform for Small Molecule Discovery
Alexza Pharmaceuticals CA – South SF Drug Delivery, Small Molecule
GRI Bio CA – La Jolla Liver Disease Small Molecule
Pragma Bio CA – San Francisco Microbial-derived small molecules
Aridis Pharmaceuticals CA – Los Gatos Monoclonal Antibody & Small Molecule Targeting Infectious Diseases
Azora Therapeutics CA – Los Angeles Novel small molecule new chemical entities for the treatment of autoimmune, inflammatory diseases
Allegro Ophthalmics CA – San Juan Capistrano Ophthalmic Small Molecules
Deep Apple Therapeutics CA – San Francisco Oral small molecule
Structure Therapeutics CA – South SF Oral small molecule drugs that can deliver biologic-like activity and specificity
Belite Bio CA – San Diego Oral Small Molecules
Zenith Epigenetics CA – San Francisco Orally-active small molecules
Venquis Therapeutics CA – San Diego Protein Degradation Small Molecules
Regen BioPharma CA – La Mesa Regenerative Medicine, Cell Therapy, Small Molecule
Geron CA – Foster City Small Molecule
Gaba Therapeutics CA – Newport Beach Small Molecule
MetVital CA – San Diego Small Molecule
WinSanTor CA – San Diego Small Molecule
CHS Pharma CA – San Francisco Small Molecule
Epiodyne CA – San Francisco Small Molecule
Nura Bio CA – South SF Small Molecule
Via Nova Therapeutics CA – Oakland Small Molecule Antivirals
Prosetta Biosciences CA – San Francisco Small Molecule antivirals
Assembly Biosciences CA – South SF Small Molecule Antivirals
AmbAgon Therapeutics CA – South SF

Small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins

Mercaptor Discoveries CA – Novato Small Molecule Captons
Cystetic Medicines CA – San Carlos

Small molecule channels that serve as molecular prosthetics for missing or dysfunctional CFTR protein

DICE Therapeutics CA – South SF Small molecule compounds that act by unlocking protein-protein interfaces
Denovicon Therapeutics CA – La Jolla Small Molecule Discovery
Orphagen Pharmaceuticals CA – San Diego Small molecule discovery
Carmot Therapeutics CA – Berkeley Small Molecule Drug Discovery
BlossomHill Therapeutics CA – San Diego Small Molecule Drug Discovery
Belharra Therapeutics CA – San Diego Small molecule drugs in oncology, immuno-oncology, autoimmune and neurodegenerative diseases
Contineum Therapeutics CA – San Diego Small Molecule for MS
Neurocentria CA – Walnut Creek Small molecule for neurological disorders
Lighthouse Pharmaceuticals CA – San Francisco Small molecule protease inhibitors
QED Therapeutics CA – San Francisco Small Molecule Targeting Tyrosine Kinase Receptors
Avenzoar Pharmaceuticals CA – Encinitas Small molecule therapeutics for cancer
Soleno Therapeutics CA – Redwood City Small Molecule, Carbon Monoxide Monitoring Device
Takeda CA – San Diego Small Molecule, Enzymes
Exelixis CA – Alameda Small Molecules
Clinuvel Pharmaceuticals CA – Burlingame Small Molecules
Zenshine Pharmaceuticals CA – Burlingame Small Molecules
VIVUS CA – Campbell Small Molecules
Agastiya Biotech CA – Carlsbad Small Molecules
Palisade Bio CA – Carlsbad Small Molecules
Reviva Pharmaceuticals CA – Cupertino Small Molecules
ARIZ Precision Medicine CA – Davis Small Molecules
Octant Biotech CA – Emeryville Small Molecules
Gilead CA – Foster City Small Molecules
Mirum Pharmaceuticals CA – Foster City Small Molecules
Bausch Health CA – Irvine Small Molecules
CalciMedica CA – La Jolla Small Molecules
MediciNova CA – La Jolla Small Molecules
Immix Biopharma CA – Los Angeles Small Molecules
MAX BioPharma CA – Los Angeles Small Molecules
Xoc Pharmaceuticals CA – Los Gatos Small Molecules
Aluda Pharmaceuticals CA – Menlo Park Small Molecules
Corcept Therapeutics CA – Menlo Park Small Molecules
Escend Pharmaceuticals CA – Menlo Park Small Molecules
Collaborative Medicinal Development CA – Mill Valley Small Molecules
Advenchen Laboratories CA – Moorpark Small Molecules
Astraea Therapeutics CA – Mountain View Small Molecules
CymaBay Therapeutics CA – Newark Small Molecules
Rain Oncology CA – Newark Small Molecules
Gilead CA – Oceanside Small Molecules
Halo Biosciences CA – Palo Alto Small Molecules
Jazz Pharmaceuticals CA – Palo Alto Small Molecules
Nalo Therapeutics CA – Palo Alto Small Molecules
Vincerx Pharma CA – Palo Alto Small Molecules
Zai Lab CA – Palo Alto Small Molecules
Astex Pharmaceuticals CA – Pleasanton Small Molecules
Xynomic Pharmaceuticals CA – Poway Small Molecules
AfaSci CA – Redwood City Small Molecules
LifeMax CA – Redwood City Small molecules
REVOLUTION Medicines CA – Redwood City Small Molecules
CuraSen Therapeutics CA – San Carlos Small Molecules
Acadia Pharmaceuticals CA – San Diego Small Molecules
BioTheryX CA – San Diego Small Molecules
Crinetics Pharmaceuticals CA – San Diego Small Molecules
Gossamer Bio CA – San Diego Small Molecules
Intercept Pharmaceuticals CA – San Diego Small Molecules
Kinnate Biopharma CA – San Diego Small Molecules
Kura Oncology CA – San Diego Small Molecules
MEI Pharma CA – San Diego Small Molecules
Neurocrine Biosciences CA – San Diego Small Molecules
NovoMedix CA – San Diego Small molecules
PHusis Therapeutics CA – San Diego Small Molecules
Vertex CA – San Diego Small Molecules
Vivreon Biosciences CA – San Diego Small Molecules
Zentalis Pharmaceuticals CA – San Diego Small Molecules
ResVerlogiX CA – San Francisco Small Molecules
Fochon Pharma CA – San Leandro Small Molecules
eFFECTOR Therapeutics CA – Solana Beach Small Molecules
Sentynl Therapeutics CA – Solana Beach Small Molecules
Cytokinetics CA – South SF Small Molecules
Rigel Pharmaceuticals CA – South SF Small Molecules
Theravance Biopharma CA – South SF Small Molecules
Titan Pharmaceuticals CA – South SF Small Molecules
Senju Pharmaceutical CA – Torrance Small Molecules
Aeovian Pharmaceuticals CA – Walnut Creek Small Molecules
Terns Pharmaceuticals CA – Foster City Small Molecules – Liver focus
Biosplice Therapeutics CA – San Diego Small Molecules Acting on Stem Cells
Teon Therapeutics CA – Redwood City Small molecules focused on GPCR targets for oncology indications
AmyriAD Therapeutics CA – Los Angeles Small Molecules for Alzheimer’s
Tosk CA – Mountain View Small Molecules for Cancer
Dermavant Sciences CA – Long Beach Small Molecules for Dermatology Indications
Origami Therapeutics CA – San Diego Small Molecules for Genetic Diseases
Tempest Therapeutics CA – Brisbane Small Molecules for Immuno-Oncology
Altay Therapeutics CA – San Francisco Small molecules for liver disease and cancer
Nine Square Therapeutics CA – South SF Small Molecules for Neuro
PharmatrophiX CA – Menlo Park Small Molecules for Neurodegenerative and other areas
Libra Therapeutics CA – San Diego Small Molecules for Neurodegenerative Indications
Modulo Bio CA – San Diego Small Molecules for Neurological Conditions
Neuropore Therapies CA – San Diego Small molecules for neurological conditions
Primmune Therapeutics CA – Carlsbad Small Molecules for Oncology
Senhwa Biosciences CA – San Diego Small Molecules for oncology
DMK Pharmaceuticals CA – San Diego Small Molecules for Substance Abuse
Biomea Fusion CA – Redwood City Small Molecules Targeting Cancer
Plexium CA – San Diego Small Molecules Targeting E3 Ligase
Quanta Therapeutics CA – South SF Small Molecules Targeting RAS-driven Cancers
Atropos Therapeutics CA – San Carlos Small Molecules Targeting Senescence
Navire Pharma CA – San Francisco Small Molecules Targeting SHP2
BridGene Biosciences CA – San Jose Small molecules that drug traditionally undruggable targets
Edison Oncology CA – Menlo Park Small Molecules, 505(b)(2)
pH Pharma CA – South SF Small Molecules, ADCs
Atengen CA – Los Angeles Small Molecules, Antibody Therapies
Ultragenyx Pharmaceutical CA – Brisbane Small Molecules, Biologics
AbbVie CA – Irvine Small Molecules, Biologics
Genentech CA – Oceanside Small Molecules, Biologics
Bristol Myers Squibb CA – Redwood City Small Molecules, Biologics
Bristol Myers Squibb CA – San Diego Small Molecules, Biologics
Janssen Pharmaceuticals CA – San Diego Small Molecules, Biologics
Odyssey Therapeutics (2) CA – San Diego Small Molecules, Biologics
Nektar Therapeutics CA – San Francisco Small Molecules, Biologics
Amgen CA – South SF Small Molecules, Biologics
Genentech CA – South SF Small Molecules, Biologics
Janssen Pharmaceuticals CA – South SF Small Molecules, Biologics
Amgen CA – Thousand Oaks Small Molecules, Biologics
Genentech CA – Vacaville Small Molecules, Biologics
Ultragenyx Pharmaceutical CA – Novato Small Molecules, Biologics, Gene Therapy, mRNA, Antisense Oligo
LadRx CA – Los Angeles Small Molecules, DNA
Maze Therapeutics CA – South SF Small Molecules, Gene Therapy, Antisense Oligonucleotides, Biologics
BeiGene CA – Emeryville Small Molecules, Monoclonal Antibodies
BCN Biosciences CA – Pasadena Small Molecules, Monoclonal Antibodies
Cidara Therapeutics CA – San Diego Small molecules, peptide
Medikine CA – San Diego Small Molecules, Peptide
Nurix Therapeutics CA – San Francisco Small Molecules, Protein Degradation
Novartis CA – San Diego Small Molecules, Vaccines, Biologics
AstraZeneca CA – South SF Small Molecules, Vaccines, Biologics
Merck CA – South SF Small Molecules, Vaccines, Biologics
Indi Molecular CA – Los Angeles Small synthetic molecule replacement for antibody-based therapeutics
f5 Therapeutics CA – San Diego Small-molecule, targeted protein degraders
Mirati Therapeutics CA – San Diego Targeted Oncology Company; Small Molecules


Related

Andrew M. Ibrahim MD, MSc, Chief Clinical Officer at the Viz.ai

Congressional hearing to discuss AI’s role in transforming U.S. healthcare

Congressmen Brett Guthrie and Morgan Griffith have announced a hearing to explore the integration of artificial intelligence (AI) in the U.S. healthcare system.

UCSF neurosurgeon criticizes effectiveness of the 340B Drug Pricing Program

UCSF neurosurgeon criticizes effectiveness of the 340B Drug Pricing Program

Anthony DiGiorgio, a neurosurgeon at the University of California, San Francisco, has expressed concerns about the 340B Drug Pricing Program.

UCSF neurosurgeon criticizes effectiveness of the 340B Drug Pricing Program

UCSF neurosurgeon calls for reform of hospital use of drug discount program

Anthony DiGiorgio, a neurosurgeon at the University of California, San Francisco, has expressed concerns regarding the 340B drug discount program.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from San Francisco Sun.